TrialDiabetes care2013

Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M).

Bo Ahrén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.